Synergistic and additive terpene-THC interactions in cannabinoid CB1 and CB2 receptors.
Noa Raz, Aharon M. Eyal, Nardine Fahoum-Khalefa, Merav Tauber, Naama Schurr, Yair Ben-Chaim
Biochemical Pharmacology June 1, 2026 DOI: 10.1016/j.bcp.2026.118185 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro pharmacological study (receptor expression in Xenopus laevis oocytes) Peer reviewed |
|---|---|
| Population | Xenopus laevis oocytes expressing cannabinoid receptors CB1R and CB2R |
| Interventions | THC Borneol Limonene Sabinene Terpineol α-Pinene Ocimene β-Caryophyllene Linalool Terpene mixtures |
| Measures | G protein-gated inwardly rectifying potassium (GIRK) channel activation |
| Topics | Cannabis |
| Key points | Several cannabis terpenes selectively potentiated THC-evoked activation at CB1R and CB2R. Isobolographic analysis suggested additive THC-terpene interactions for some terpenes and synergistic interactions for others, including borneol, limonene, sabinene, terpineol, α-pinene and ocimene at CB1R, and β-caryophyllene and linalool at CB2R. Terpene mixtures showed dose-dependent CB1R activation, and several mixtures synergistically enhanced THC responses. |
Abstract
Cannabis terpenes are widely recognized for shaping the plant's aromatic and sensory profiles. Yet, their pharmacological role in cannabis is less established. Recent work demonstrated that several cannabis terpenes can activate cannabinoid receptors type 1 and 2 (CB1R and CB2R) as low-efficacy agonists, raising the possibility that they may also modulate the activation at these receptors by Δ9-tetrahydrocannabinol (THC), through orthosteric or allosteric mechanisms. Here, we systematically investigated the effects of individual terpenes and of terpene mixtures on THC-evoked activation at CB1R and CB2R, expressed in Xenopus laevis oocytes. Using G protein-gated inwardly rectifying potassium (GIRK) channel activation as a functional readout, we quantified concentration-response relationships for THC alone and in combination with terpenes, and applied isobolographic analysis to distinguish additive, synergistic, and antagonistic interactions. We found that several terpenes selectively potentiated THC activation at CB1R and CB2R. Isobolographic analysis suggested additive THC-terpene interactions for some terpenes, and synergistic interactions for others, including borneol, limonene, sabinene, terpineol, α-pinene and ocimene at CB1R, and β-caryophyllene and linalool at CB2R. Terpene mixtures displayed dose-dependent CB1R activation, and several mixtures synergistically enhanced THC responses. Together, our findings suggest that cannabis terpenes may act as both partial orthosteric agonists and allosteric modulators at CB1R and CB2R. These results provide a mechanistic framework for cannabinoid-terpene synergy and highlight the importance of receptor specificity and of formulation design in shaping terpene mediated activation. These findings stress the need for terpenes selection for formulations tailor for specified medicinal needs.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.